![]() |
市場調查報告書
商品編碼
2024516
電泳設備市場報告:按產品類型、類別、最終用戶和地區分類(2026-2034 年)Electrophoresis Equipment Market Report by Product Type, Type, End User, and Region 2026-2034 |
||||||
2025年全球電泳設備市場規模達21億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到31億美元,2026年至2034年的複合年成長率為4.20%。推動這一市場趨勢的關鍵因素包括生物技術的持續進步、對個人化醫療需求的成長、遺傳疾病盛行率的上升、研究活動的活性化以及產品在全球製藥、診斷和學術研究機構中應用範圍的擴大。
電泳是一種實驗室儀器,用於根據分子的電荷、大小和結合親和性分離或純化分子。透過施加電流,電泳被廣泛用於分析核酸、質體、去氧核糖核酸(DNA)、核糖核酸(RNA)、蛋白質以及這些大分子的片段等生物大分子。電泳實驗使用電泳槽,電泳槽通常是一個硬質塑膠盒或容器,一端是陰極,另一端是陽極。電泳的應用範圍十分廣泛,包括疫苗和抗體分析、血紅素疾病以及藥物品管。因此,電泳也被廣泛應用於法醫學調查、分子生物學、遺傳學和微生物實驗室,用於確定DNA的來源和操作蛋白質分子。
全球研發活動的顯著成長為市場帶來了光明的前景。電泳設備在日益增加的生物研究計畫和新藥研發工作中發揮著不可或缺的作用。遺傳疾病、癌症及其他多種疾病治療的日益複雜化也推動了市場成長。此外,該產品在製藥業的廣泛應用,用於各種製劑的品管,包括藥物含量分析和鑑定、DNA片段研究以及抗生素和疫苗測試,也是推動市場成長的另一個因素。毛細管電泳在微生物檢測和分離過程中的日益普及也促進了市場成長。此外,在新冠疫情期間,毛細管電泳被廣泛用於開發經濟高效的SARS-CoV-2新型變種鑑定方法,使各地機構能夠檢測和追蹤SARS-CoV-2突變,這進一步加速了市場成長。同時,微流體電泳平台在聚丙烯醯胺凝膠電泳的應用也取得了非常可觀的成果,也推動了市場成長。此外,監管核准的增加以及用於檢測和鑑定血清和尿液中單株蛋白的免疫分型設備的推出,正積極推動市場成長。其他因素,例如廣泛的研發活動、醫療基礎設施的改善以及政府實施的與藥品品管和製程驗證相關的各項政府措施,預計也將促進市場成長。
The global electrophoresis equipment market size reached USD 2.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.1 Billion by 2034, exhibiting a growth rate (CAGR) of 4.20% during 2026-2034. The ongoing advancements in biotechnology, increased demand for personalized medicine, rising prevalence of genetic disorders, growing research activities, and expanding product applications in pharmaceuticals, diagnostics, and academic research institutions globally are some of the key factors supporting the market trends.
Electrophoresis equipment is a laboratory tool used to separate or purify molecules based on charge, size, and binding affinity. It is widely used to analyze large molecules, such as nucleic acids, plasmids, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), proteins, and fragments of these macromolecules by passing an electric current from end to end. Electrophoresis equipment is manufactured using an electrophoretic chamber which consists of a hard plastic box or tank with a cathode at one end and an anode at the opposite end. It is used in various applications, including vaccines, antibody analysis, hemoglobinopathies, and drug quality control. As a result, electrophoresis equipment finds extensive applications in forensic investigation, molecular biology, genetics, and microbiological labs to identify source DNA and manipulate protein molecules.
A significant increase in research and development activities across the globe is creating a positive outlook for the market. Electrophoresis equipment is extensively helpful in the rising number of ongoing biological research projects and initiatives regarding novel medicine discovery. In line with this, the increasing complexities in the treatment of diseases, such as genetically transmitted diseases, cancer, and various disorders, are favoring the market growth. Moreover, the widespread product adoption in the pharmaceutical industry for quality control of various formulations by analyzing and identifying the drug content, studying DNA fragments, and testing antibiotics and vaccines are acting as another growth-inducing factor. Along with this, the increasing utilization of capillary electrophoresis in the process of microbial detection and separation is propelling the market growth. Additionally, the widespread adoption of capillary electrophoresis during the COVID-19 pandemic to develop a cost-effective identification approach for novel SARS-CoV-2 variants, allowing local facilities to test and track SARS-CoV-2 variations is providing an impetus to the market growth. Apart from this, the introduction of microfluidic electrophoresis platforms to polyacrylamide gel electrophoresis that offers highly promising results is facilitating the market growth. Furthermore, increasing approvals from the regulatory authorities and the launch of an immunotyping device used to detect and identify monoclonal proteins in serum and urine are positively influencing the market growth. Other factors, including extensive research and development (R&D) activities, improvements in the healthcare infrastructure and the implementation of various government initiatives regarding pharmaceutical products' quality control and process validation, are anticipated to drive the market growth.
This report provides an analysis of the key trends in each segment of the global electrophoresis equipment market, along with forecasts at the global, regional, and country level from 2026-2034. The report has categorized the market based on product type, type and end user.
The report has also provided a detailed breakup and analysis of the electrophoresis equipment market based on the product type. This includes gel electrophoresis systems, capillary electrophoresis systems, and electrophoresis accessories. According to the report, gel electrophoresis systems represented the largest segment.
The report has also provided a detailed breakup and analysis of the electrophoresis equipment market based on the end user. This includes hospitals and diagnostics centers, academic and research institutes, pharmaceutical and biotechnology companies, and others. According to the report, pharmaceutical and biotechnology companies represented the largest segment.
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for electrophoresis equipment. Some of the factors driving the North America electrophoresis equipment market growth included its extensive application in the pharmaceutical industry, several product innovations, extensive research and development activities, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global electrophoresis equipment market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Agilent Technologies Inc., Bio-Rad Laboratories Inc., Cleaver Scientific Ltd., Edvotek Inc., Flinn Scientific Inc., Hoefer Inc. (Harvard Bioscience Inc.), Lonza Group AG, Lumex Instruments, Merck KGaA, Nova-Tech International Inc., PerkinElmer Inc., Qiagen N.V., SERVA Electrophoresis GmbH, Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.